Approval · Notice of Compliance 38228 · 2026
TRIMBOW: Notice of Compliance 38228
Issued September 2, 2026
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 38228
- Date
- September 2, 2026
- Company
- Chiesi Farmaceutici S.P.A.Parma, Italy
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Change in the composition of a dosage form. Change in the drug product manufacturing process
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| TRIMBOW | Not yet assigned | — |
Medicinal ingredients
- BECLOMETHASONE DIPROPIONATE 100 MCG per ACT
- FORMOTEROL FUMARATE DIHYDRATE 6 MCG per ACT
- GLYCOPYRRONIUM BROMIDE 10 MCG per ACT